UK markets closed

Teva Pharmaceutical Industries Limited (0LER.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
9.73-0.15 (-1.47%)
At close: 06:59PM GMT
Full screen
Previous close9.88
Bid9.02 x 0
Ask10.45 x 0
Day's range9.63 - 10.00
52-week range7.10 - 11.25
Avg. volume9,812
Market cap13.463B
Beta (5Y monthly)1.15
PE ratio (TTM)N/A
EPS (TTM)-1.90
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.22
  • Business Wire

    Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment

    PARSIPPANY, N.J., November 30, 2023--Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today closing of its collaboration deal to co-develop and co-commercialize asset TEV ‘574 with Sanofi (EURONEXT: SAN and NASDAQ: SNY). TEV '574 is currently in Phase 2b clinical trials for the treatment of ulcerative colitis and Crohn's disease, two types of inflammatory bowel disease.

  • Yahoo Finance Video

    Teva Pharmaceutical upgraded to 'Buy' at UBS

    UBS upgraded Teva Pharmaceutical (TEVA) to Buy from Neutral and raised its price target on the stock to $13 per share. UBS sees Teva "uniquely positioned to undergo a significant transition" to a more brand-focused company.  Yahoo Finance anchors Seana Smith and Diane King Hall break down UBS's call on Teva and the stock's recent gains. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.


    Midday movers: Affirm, Amazon, and More

    (Updated - November 27, 2023 1:12 PM EST)